G-Protein Coupled Receptor (GPCR) Targeting: Technologies and Global Markets
Report Scope:
This report on the global market for G protein-coupled receptor (GPCR) targeting technologies analyzes the current landscape, including market size and growth trends and segments the market by assay type, product type, application and region. Assay categories include cAMP assays and cGMP assays, calcium functional assays, arrestin functional assays, radioligand binding and GTPgammaS functional assays, reporter gene assays and others. Product types include cell lines, detection kits, cell culture reagents and ligands. Applications include oncology, cardiovascular diseases (CVDs), central nervous system diseases, respiratory diseases and others.
The regions looked at are North America (the U.S., Canada and Mexico), Europe (Germany, the U.K., France, Italy, Spain, Russia and Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia, Singapore and Rest of APAC) and the Rest of the World (South America, the Middle East and Africa). The report also includes profiles of leading companies and discusses industry trends, significant products, mergers and acquisitions, and other collaborations or partnerships.
In-text citations are given by the author and the year that the research or study was published. More details on these sources can be found in the table listing them in the Appendix.
Report Includes:
This report on the global market for G protein-coupled receptor (GPCR) targeting technologies analyzes the current landscape, including market size and growth trends and segments the market by assay type, product type, application and region. Assay categories include cAMP assays and cGMP assays, calcium functional assays, arrestin functional assays, radioligand binding and GTPgammaS functional assays, reporter gene assays and others. Product types include cell lines, detection kits, cell culture reagents and ligands. Applications include oncology, cardiovascular diseases (CVDs), central nervous system diseases, respiratory diseases and others.
The regions looked at are North America (the U.S., Canada and Mexico), Europe (Germany, the U.K., France, Italy, Spain, Russia and Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia, Singapore and Rest of APAC) and the Rest of the World (South America, the Middle East and Africa). The report also includes profiles of leading companies and discusses industry trends, significant products, mergers and acquisitions, and other collaborations or partnerships.
In-text citations are given by the author and the year that the research or study was published. More details on these sources can be found in the table listing them in the Appendix.
Report Includes:
- 22 data tables and 43 additional tables
- An analysis of the global market and technologies for G-protein coupled receptor (GPCR) targeting
- Analyses of the global market trends, with data from 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029
- Evaluation of the market potential for GPCR targeting technology, industry growth drivers, and forecasts for this market’s segments and sub-segments
- Estimates of the market size and revenue forecast for the global GPCR targeting technology market in USD millions, and a corresponding market share analysis by assay type, product type, application and region
- Discussion of the major market dynamics and shifts, and the regulations, industry challenges and macroeconomic factors affecting the demand for GPCR targeting technology over the coming years
- A look at the recent technological breakthroughs in the use of GPCR targeting technology, and how it has propelled the rapid growth in genetic engineering and advanced pharmacological research
- Review of the patent filings and research publications for innovations in GPCR targeting technology
- Discussion on the industry’s ESG challenges and practices
- Identification of the companies that are best positioned to meet this demand because of their proprietary technologies, strategic alliances or other advantages
- Insights into the industry structure for GPCR targeting technology, the competitive landscape, clinical trials and ongoing research activity
- Profiles of the major players in the industry, including Promega Corp., Revvity Inc., Thermo Fisher Scientific Inc., Enzo Biochem Inc., and Danaher Corp.
CHAPTER 1 EXECUTIVE SUMMARY
Market Outlook
Scope of Report
Market Summary
CHAPTER 2 MARKET OVERVIEW
Overview
Types of GPCRs
Introduction of GPCR Cellular Responses
Importance of GPCRs in Disease Physiology
Regulatory Aspect
CHAPTER 3 MARKET DYNAMICS
Overview
Market Drivers
Rising Incidence of Chronic Diseases
Growing Demand for GPCR Drugs
Technological Advances in GPCR Research
Market Restraints
Challenges of Drug Discovery
Limitations of GPCR Structural Studies
Market Opportunities
Personalized Cancer Therapy
CHAPTER 4 EMERGING TECHNOLOGIES AND DEVELOPMENTS
Overview
Emerging Technologies
Novel Screening Technology
Structural Analysis in GPCR-Targeted Drug Discovery
Experimental Screening in GPCR-Targeted Drug Discovery
Patent Analysis
Patent Review, by Applicant
CHAPTER 5 MARKET SEGMENTATION ANALYSIS
Market Overview
Segmentation Breakdown
GPCR-Targeting: Technologies and Global Markets
Market Analysis by Assay Type
cAMP Assays and cGMP Assays
Calcium Functional Assays
Arrestin Functional Assays
Radioligand-Binding and GTPgammaS Functional Assays
Reporter Gene Assays
Other Assays
Market Analysis by Product Type
Cell Lines
Detection Kits
Cell Culture Reagents
Ligands
Market Analysis by Application
Oncology/Cancers
Cardiovascular Diseases
Central Nervous System Diseases
Respiratory Diseases
Other Diseases
Geographic Breakdown
Market Analysis by Region
North America
Europe
Asia-Pacific
Rest of the World
CHAPTER 6 COMPETITIVE INTELLIGENCE
Overview
Ranking of Companies in the Industry
Venture Fundings in the Industry
CHAPTER 7 SUSTAINABILITY IN THE GPCR-TARGETING TECHNOLOGIES INDUSTRY: AN ESG PERSPECTIVE
Sustainability in the Global GPCR Industry
ESG Risks and Ratings: Understanding the Data
BCC Research Viewpoint
CHAPTER 8 APPENDIX
Sources
Abbreviations
Company Profiles
AGILENT TECHNOLOGIES INC.
BD
DANAHER CORP.
ENZO BIOCHEM INC.
EPICS THERAPEUTICS
EUROFINS SCIENTIFIC
INTERAX BIOTECH AG
MERCK KGAA
ORION BIOTECHNOLOGY CANADA LTD.
PROMEGA CORP.
QIAGEN
REVVITY
TECTONIC THERAPEUTIC
THERMO FISHER SCIENTIFIC INC.
WUXI APPTEC
12. LIST OF TABLES
Summary Table : Global Market for GPCR-Targeting Technologies, by Region, Through 2029
Table 1 : Number of New Cases and Deaths Due to Various Cancers, Globally, 2022
Table 2 : U.S. NIH Funding for Various Diseases and Conditions, 2019–2023
Table 3 : FDA-Approved Drugs Targeting GPCR, 2020–2024
Table 4 : Patents Issued for GPCRs, by Applicant, January 2023–December 2024
Table 5 : Global Market for GPCR-Targeting Technologies, Through 2029
Table 6 : Global Market for GPCR Targeting Technologies, by Assay Type, Through 2029
Table 7 : Global Market for GPCR-Targeting Technologies, by Product Type, Through 2029
Table 8 : Global Market for GPCR-Targeting Technologies, by Application, Through 2029
Table 9 : GPCRs, Ligands and Their Locations in the Body
Table 10 : GPCR Families and Their Role in CNS Disorders
Table 11 : Glucocorticoid Effects Mediated by Transactivation Mechanisms in Airway Structural Cells
Table 12 : Global Market for GPCR-Targeting Technologies, by Region, Through 2029
Table 13 : North American Market for GPCR-Targeting Technologies, by Country, Through 2029
Table 14 : European Market for GPCR-Targeting Technologies, by Country, Through 2029
Table 15 : APAC Market for GPCR-Targeting Technologies, by Country, Through 2029
Table 16 : ROW Market for GPCR-Targeting Technologies, by Subregion, Through 2029
Table 17 : Market Rankings of Leading Companies in the GPCR-Targeting Technologies Industry, 2023
Table 18 : Funding for GPCR-Targeting Technologies Companies, 2022-2024
Table 19 : ESG Rankings for Major GPCR Companies, 2024*
Table 20 : Sources Used in this Report
Table 21 : Abbreviations Used in this Report
Table 22 : Agilent Technologies Inc.: Company Snapshot
Table 23 : Agilent Technologies Inc.: Financial Performance, FY 2022 and 2023
Table 24 : Agilent Technologies Inc.: Product Portfolio
Table 25 : BD: Company Snapshot
Table 26 : BD: Financial Performance, FY 2023 and 2024
Table 27 : BD: Product Portfolio
Table 28 : Danaher Corp.: Company Snapshot
Table 29 : Danaher Corp.: Financial Performance, FY 2022 and 2023
Table 30 : Danaher Corp.: Product Portfolio
Table 31 : Enzo Biochem Inc.: Company Snapshot
Table 32 : Enzo Biochem Inc.: Financial Performance, FY 2023 and 2024
Table 33 : Enzo Biochem Inc.: Product Portfolio
Table 34 : Epics Therapeutics: Company Snapshot
Table 35 : Epics Therapeutics: Product Portfolio
Table 36 : Eurofins Scientific: Company Snapshot
Table 37 : Eurofins Scientific: Financial Performance, FY 2022 and 2023
Table 38 : Eurofins Scientific: Product Portfolio
Table 39 : InterAx Biotech AG: Company Snapshot
Table 40 : InterAx Biotech AG: Product Portfolio
Table 41 : Merck KGaA: Company Snapshot
Table 42 : Merck KGaA: Financial Performance, FY 2022 and 2023
Table 43 : Merck KGaA: Product Portfolio
Table 44 : Orion Biotechnology Canada Ltd.: Company Snapshot
Table 45 : Orion Biotechnology Canada Ltd.: Product Portfolio
Table 46 : Promega Corp.: Company Snapshot
Table 47 : Promega Corp.: Product Portfolio
Table 48 : Promega Corp.: News/Key Developments, 2023 and 2024
Table 49 : Qiagen: Company Snapshot
Table 50 : Qiagen: Financial Performance, FY 2022 and 2023
Table 51 : Qiagen: Product Portfolio
Table 52 : Revvity: Company Snapshot
Table 53 : Revvity: Financial Performance, FY 2022 and 2023
Table 54 : Revvity: Product Portfolio
Table 55 : Revvity: News/Key Developments, 2021
Table 56 : Tectonic Therapeutic: Company Snapshot
Table 57 : Tectonic Therapeutic: Product Portfolio
Table 58 : Tectonic Therapeutic: News/Key Developments, 2024
Table 59 : Thermo Fisher Scientific Inc.: Company Snapshot
Table 60 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
Table 61 : Thermo Fisher Scientific Inc.: Product Portfolio
Table 62 : Wuxi AppTec: Company Snapshot
Table 63 : Wuxi AppTec: Financial Performance, FY 2022 and 2023
Table 64 : Wuxi AppTec: Product Portfolio
12. LIST OF FIGURES
Summary Figure : Global Market Shares for GPCR-Targeting Technologies, by Region, 2023
Figure 1 : Snapshot of the Market Dynamics for GPCR-Targeting Technologies
Figure 2 : Global Market Shares for GPCR-Targeting Technologies, by Assay Type, 2023
Figure 3 : Global Market Shares for GPCR-Targeting Technologies, by Product Type, 2023
Figure 4 : Global Market Shares for GPCR-Targeting Technologies, by Application, 2023
Figure 5 : Global Market Shares for GPCR-Targeting Technologies, by Region, 2023
Figure 6 : North American Market Shares for GPCR-Targeting Technologies, by Country, 2023
Figure 7 : European Market Shares for GPCR-Targeting Technologies, by Country, 2023
Figure 8 : APAC Market Shares for GPCR-Targeting Technologies, by Country, 2023
Figure 9 : ROW Market Shares for GPCR-Targeting Technologies, by Subregion, 2023
Figure 10 : Agilent Technologies Inc.: Revenue Share, by Business Unit, FY 2023
Figure 11 : Agilent Technologies Inc.: Revenue Share, by Country/Region, FY 2023
Figure 12 : BD: Revenue Share, by Business Unit, FY 2024
Figure 13 : BD: Revenue Share, by Country/Region, FY 2024
Figure 14 : Danaher Corp.: Revenue Share, by Business Unit, FY 2023
Figure 15 : Danaher Corp.: Revenue Share, by Country/Region, FY 2023
Figure 16 : Enzo Biochem Inc.: Revenue Share, by Country/Region, FY 2023
Figure 17 : Eurofins Scientific: Revenue Share, by Business Unit, FY 2023
Figure 18 : Eurofins Scientific: Revenue Share, by Country/Region, FY 2023
Figure 19 : Merck KGaA: Revenue Share, by Business Unit, FY 2023
Figure 20 : Merck KGaA: Revenue Share, by Country/Region, FY 2023
Figure 21 : Qiagen: Revenue Share, by Business Unit, FY 2023
Figure 22 : Qiagen: Revenue Share, by Country/Region, FY 2023
Figure 23 : Revvity: Revenue Share, by Business Unit, FY 2023
Figure 24 : Revvity: Revenue Share, by Country/Region, FY 2023
Figure 25 : Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, 2023
Figure 26 : Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, 2023
Figure 27 : Wuxi AppTec: Revenue Share, by Business Unit, 2023
Figure 28 : Wuxi AppTec: Revenue Share, by Country/Region, 2023
Market Outlook
Scope of Report
Market Summary
CHAPTER 2 MARKET OVERVIEW
Overview
Types of GPCRs
Introduction of GPCR Cellular Responses
Importance of GPCRs in Disease Physiology
Regulatory Aspect
CHAPTER 3 MARKET DYNAMICS
Overview
Market Drivers
Rising Incidence of Chronic Diseases
Growing Demand for GPCR Drugs
Technological Advances in GPCR Research
Market Restraints
Challenges of Drug Discovery
Limitations of GPCR Structural Studies
Market Opportunities
Personalized Cancer Therapy
CHAPTER 4 EMERGING TECHNOLOGIES AND DEVELOPMENTS
Overview
Emerging Technologies
Novel Screening Technology
Structural Analysis in GPCR-Targeted Drug Discovery
Experimental Screening in GPCR-Targeted Drug Discovery
Patent Analysis
Patent Review, by Applicant
CHAPTER 5 MARKET SEGMENTATION ANALYSIS
Market Overview
Segmentation Breakdown
GPCR-Targeting: Technologies and Global Markets
Market Analysis by Assay Type
cAMP Assays and cGMP Assays
Calcium Functional Assays
Arrestin Functional Assays
Radioligand-Binding and GTPgammaS Functional Assays
Reporter Gene Assays
Other Assays
Market Analysis by Product Type
Cell Lines
Detection Kits
Cell Culture Reagents
Ligands
Market Analysis by Application
Oncology/Cancers
Cardiovascular Diseases
Central Nervous System Diseases
Respiratory Diseases
Other Diseases
Geographic Breakdown
Market Analysis by Region
North America
Europe
Asia-Pacific
Rest of the World
CHAPTER 6 COMPETITIVE INTELLIGENCE
Overview
Ranking of Companies in the Industry
Venture Fundings in the Industry
CHAPTER 7 SUSTAINABILITY IN THE GPCR-TARGETING TECHNOLOGIES INDUSTRY: AN ESG PERSPECTIVE
Sustainability in the Global GPCR Industry
ESG Risks and Ratings: Understanding the Data
BCC Research Viewpoint
CHAPTER 8 APPENDIX
Sources
Abbreviations
Company Profiles
AGILENT TECHNOLOGIES INC.
BD
DANAHER CORP.
ENZO BIOCHEM INC.
EPICS THERAPEUTICS
EUROFINS SCIENTIFIC
INTERAX BIOTECH AG
MERCK KGAA
ORION BIOTECHNOLOGY CANADA LTD.
PROMEGA CORP.
QIAGEN
REVVITY
TECTONIC THERAPEUTIC
THERMO FISHER SCIENTIFIC INC.
WUXI APPTEC
12. LIST OF TABLES
Summary Table : Global Market for GPCR-Targeting Technologies, by Region, Through 2029
Table 1 : Number of New Cases and Deaths Due to Various Cancers, Globally, 2022
Table 2 : U.S. NIH Funding for Various Diseases and Conditions, 2019–2023
Table 3 : FDA-Approved Drugs Targeting GPCR, 2020–2024
Table 4 : Patents Issued for GPCRs, by Applicant, January 2023–December 2024
Table 5 : Global Market for GPCR-Targeting Technologies, Through 2029
Table 6 : Global Market for GPCR Targeting Technologies, by Assay Type, Through 2029
Table 7 : Global Market for GPCR-Targeting Technologies, by Product Type, Through 2029
Table 8 : Global Market for GPCR-Targeting Technologies, by Application, Through 2029
Table 9 : GPCRs, Ligands and Their Locations in the Body
Table 10 : GPCR Families and Their Role in CNS Disorders
Table 11 : Glucocorticoid Effects Mediated by Transactivation Mechanisms in Airway Structural Cells
Table 12 : Global Market for GPCR-Targeting Technologies, by Region, Through 2029
Table 13 : North American Market for GPCR-Targeting Technologies, by Country, Through 2029
Table 14 : European Market for GPCR-Targeting Technologies, by Country, Through 2029
Table 15 : APAC Market for GPCR-Targeting Technologies, by Country, Through 2029
Table 16 : ROW Market for GPCR-Targeting Technologies, by Subregion, Through 2029
Table 17 : Market Rankings of Leading Companies in the GPCR-Targeting Technologies Industry, 2023
Table 18 : Funding for GPCR-Targeting Technologies Companies, 2022-2024
Table 19 : ESG Rankings for Major GPCR Companies, 2024*
Table 20 : Sources Used in this Report
Table 21 : Abbreviations Used in this Report
Table 22 : Agilent Technologies Inc.: Company Snapshot
Table 23 : Agilent Technologies Inc.: Financial Performance, FY 2022 and 2023
Table 24 : Agilent Technologies Inc.: Product Portfolio
Table 25 : BD: Company Snapshot
Table 26 : BD: Financial Performance, FY 2023 and 2024
Table 27 : BD: Product Portfolio
Table 28 : Danaher Corp.: Company Snapshot
Table 29 : Danaher Corp.: Financial Performance, FY 2022 and 2023
Table 30 : Danaher Corp.: Product Portfolio
Table 31 : Enzo Biochem Inc.: Company Snapshot
Table 32 : Enzo Biochem Inc.: Financial Performance, FY 2023 and 2024
Table 33 : Enzo Biochem Inc.: Product Portfolio
Table 34 : Epics Therapeutics: Company Snapshot
Table 35 : Epics Therapeutics: Product Portfolio
Table 36 : Eurofins Scientific: Company Snapshot
Table 37 : Eurofins Scientific: Financial Performance, FY 2022 and 2023
Table 38 : Eurofins Scientific: Product Portfolio
Table 39 : InterAx Biotech AG: Company Snapshot
Table 40 : InterAx Biotech AG: Product Portfolio
Table 41 : Merck KGaA: Company Snapshot
Table 42 : Merck KGaA: Financial Performance, FY 2022 and 2023
Table 43 : Merck KGaA: Product Portfolio
Table 44 : Orion Biotechnology Canada Ltd.: Company Snapshot
Table 45 : Orion Biotechnology Canada Ltd.: Product Portfolio
Table 46 : Promega Corp.: Company Snapshot
Table 47 : Promega Corp.: Product Portfolio
Table 48 : Promega Corp.: News/Key Developments, 2023 and 2024
Table 49 : Qiagen: Company Snapshot
Table 50 : Qiagen: Financial Performance, FY 2022 and 2023
Table 51 : Qiagen: Product Portfolio
Table 52 : Revvity: Company Snapshot
Table 53 : Revvity: Financial Performance, FY 2022 and 2023
Table 54 : Revvity: Product Portfolio
Table 55 : Revvity: News/Key Developments, 2021
Table 56 : Tectonic Therapeutic: Company Snapshot
Table 57 : Tectonic Therapeutic: Product Portfolio
Table 58 : Tectonic Therapeutic: News/Key Developments, 2024
Table 59 : Thermo Fisher Scientific Inc.: Company Snapshot
Table 60 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
Table 61 : Thermo Fisher Scientific Inc.: Product Portfolio
Table 62 : Wuxi AppTec: Company Snapshot
Table 63 : Wuxi AppTec: Financial Performance, FY 2022 and 2023
Table 64 : Wuxi AppTec: Product Portfolio
12. LIST OF FIGURES
Summary Figure : Global Market Shares for GPCR-Targeting Technologies, by Region, 2023
Figure 1 : Snapshot of the Market Dynamics for GPCR-Targeting Technologies
Figure 2 : Global Market Shares for GPCR-Targeting Technologies, by Assay Type, 2023
Figure 3 : Global Market Shares for GPCR-Targeting Technologies, by Product Type, 2023
Figure 4 : Global Market Shares for GPCR-Targeting Technologies, by Application, 2023
Figure 5 : Global Market Shares for GPCR-Targeting Technologies, by Region, 2023
Figure 6 : North American Market Shares for GPCR-Targeting Technologies, by Country, 2023
Figure 7 : European Market Shares for GPCR-Targeting Technologies, by Country, 2023
Figure 8 : APAC Market Shares for GPCR-Targeting Technologies, by Country, 2023
Figure 9 : ROW Market Shares for GPCR-Targeting Technologies, by Subregion, 2023
Figure 10 : Agilent Technologies Inc.: Revenue Share, by Business Unit, FY 2023
Figure 11 : Agilent Technologies Inc.: Revenue Share, by Country/Region, FY 2023
Figure 12 : BD: Revenue Share, by Business Unit, FY 2024
Figure 13 : BD: Revenue Share, by Country/Region, FY 2024
Figure 14 : Danaher Corp.: Revenue Share, by Business Unit, FY 2023
Figure 15 : Danaher Corp.: Revenue Share, by Country/Region, FY 2023
Figure 16 : Enzo Biochem Inc.: Revenue Share, by Country/Region, FY 2023
Figure 17 : Eurofins Scientific: Revenue Share, by Business Unit, FY 2023
Figure 18 : Eurofins Scientific: Revenue Share, by Country/Region, FY 2023
Figure 19 : Merck KGaA: Revenue Share, by Business Unit, FY 2023
Figure 20 : Merck KGaA: Revenue Share, by Country/Region, FY 2023
Figure 21 : Qiagen: Revenue Share, by Business Unit, FY 2023
Figure 22 : Qiagen: Revenue Share, by Country/Region, FY 2023
Figure 23 : Revvity: Revenue Share, by Business Unit, FY 2023
Figure 24 : Revvity: Revenue Share, by Country/Region, FY 2023
Figure 25 : Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, 2023
Figure 26 : Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, 2023
Figure 27 : Wuxi AppTec: Revenue Share, by Business Unit, 2023
Figure 28 : Wuxi AppTec: Revenue Share, by Country/Region, 2023
